Table 2. Number and site of relapse according to adjuvant treatment and stage of disease.

Variable	No.	Relapse	Site of relapse			p-value*
			Pelvic	Distant	Pelvic and distant
Observation	55	17 (30.9)	7 (12.7)	8 (14.6 )	2 (3.6)	0.084
Stage I-II	48	12 (25)	5 (10.4)	6 (12.5)	1 (2)
Stage III	7	5 (71.4)	2 (28.6)	2 (28.6)	1 (14.3)
EBRT	98	32 (32.7)	12 (12.2)	15 (15.3)	4 (4.1)	0.039
Stage I-II	60	21 (35)	9 (15)	10 (16.7)	1 (1.7)
Stage III	38	11 (28.9)	3 (7.9)	5 (13.2)	3 (7.9)
Chemotherapy	59	22 (37.3)	9 (15.3)	10 (16.9)	3 (5.1)	0.02
Stage I-II	13	3 (23.1)	2 (15.4)	1 (7.7)	0
Stage III	46	19 (41.3)	7 (15.2)	9 (19.6)	3 (6.5)
Sequential chemo-EBRT	42	7 (16.7)	2 (4.8)	3 (7.1)	1 (2.4)	-
Stage I-II	13	1 (7.7)	0	1 (7.7)	0
Stage III	29	6 (20.7)	2 (6.9)	1 (3.4)	1 (3.4)

Values are presented as number (%).

EBRT, external beam radiotherapy.

^*Fisher exact test for the reduction of relapse compared with sequential chemo-EBRT.